XML 46 R36.htm IDEA: XBRL DOCUMENT v3.23.3
Restatement of Previously Issued Financial Statements (Unaudited) (Details) - USD ($)
 1 Months Ended 3 Months Ended 8 Months Ended 9 Months Ended
Jan. 18, 2023
Sep. 30, 2023
Jun. 30, 2023
Mar. 31, 2023
Sep. 30, 2022
Jun. 30, 2022
Mar. 31, 2022
Sep. 30, 2023
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Balance Sheet:                      
Deferred offering costs         $ 555,729         $ 555,729  
Accrued offering costs         379,024         379,024  
Accrued expenses         46,655         46,655  
Accumulated deficit   $ (4,546,904)     (51,814)     $ (4,546,904) $ (4,546,904) (51,814) $ (77,000)
Statement of Operations:                      
Formation and operating costs                   46,755  
Net loss $ (6,646) $ 1,769,706 $ 1,435,806 $ 1,143,965 $ (10,508) $ (10,278) $ (25,969) $ 4,356,123 4,349,477 $ (46,755)  
Basic net income per share (in dollars per share)         $ 0.00         $ (0.01)  
Diluted net loss per share (in dollars per share)                   $ (0.01)  
Statement of Cash Flows                      
Net loss                 $ 4,349,477 $ (46,755)  
Cash Flows from Operating Activities:                      
Accrued expenses                   46,655  
Supplemental Disclosure of Non-cash Financing Activities:                      
Deferred offering costs included in accrued offering costs                   555,729  
As Previously Reported                      
Balance Sheet:                      
Deferred offering costs         $ 602,384         602,384  
Accrued offering costs         425,679         425,679  
Accumulated deficit         (5,159)         (5,159)  
Statement of Operations:                      
Formation and operating costs                   100  
Net loss                   $ (100)  
Basic net income per share (in dollars per share)                   $ 0.00  
Diluted net loss per share (in dollars per share)                   $ 0.00  
Statement of Cash Flows                      
Net loss                   $ (100)  
Supplemental Disclosure of Non-cash Financing Activities:                      
Deferred offering costs included in accrued offering costs                   602,384  
Adjustment                      
Balance Sheet:                      
Deferred offering costs         (46,655)         (46,655)  
Accrued offering costs         (46,655)         (46,655)  
Accrued expenses         46,655         46,655  
Accumulated deficit         $ (46,655)         (46,655)  
Statement of Operations:                      
Formation and operating costs                   46,655  
Net loss                   $ (46,655)  
Basic net income per share (in dollars per share)                   $ (0.01)  
Diluted net loss per share (in dollars per share)                   $ (0.01)  
Statement of Cash Flows                      
Net loss                   $ (46,655)  
Cash Flows from Operating Activities:                      
Accrued expenses                   46,655  
Supplemental Disclosure of Non-cash Financing Activities:                      
Deferred offering costs included in accrued offering costs                   $ (46,655)